psilocybin
Research Roundup: Dry January for potheads, and why you shouldn’t inject shrooms
The latest edition of CannCentral’s regular roundup of research into cannabis and psychedelics from scientists around the globe
Havn Life Sciences to study psilocybin’s effect on the human immune system
Specifically, the study will determine if a single dose of psilocybin extract can affect the body’s inflammatory response
Trudeau Liberals reject call by thousands of Canadians to decriminalize psychedelics
Close to 15,000 petitioners asked the government to recognize “sacramental and medicinal plants”
Liberty cap: the surprising tale of how Europe’s magic mushroom got its name
It traces a path back through the political revolutions of the early modern period, via the murder of the tyrant Julius Caesar, to a conical cap worn by Rome’s former slaves
Research Roundup: small study shows psilocybin effective in treating depression
Also: Israeli researchers say cannabis can be a safe and effective treatment for chronic pain
Havn Life Sciences chief psychedelic officer marries love of plants with desire to help
Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.
Enhancer boosts psilocin potential in psychedelic therapy to treat PTSD
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
MDMA shows potential in PTSD treatment; more research needed on other psychedelics
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
UC Berkeley is launching a new centre for psychedelic research
The centre’s cofounders include UC Berkeley neuroscientist David Presti, psychologist Dacher Keltner, and journalism professor Michael Pollan